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INTRODUCTION
Respiratory infections are the most common reason for seeking 
medical advice, responsible for approximately 50-60% of all com-
munity-acquired infections [1]. High-intensity endurance training 
increases the risk of upper respiratory tract infections (URTI) by 
impairing the immune function in athletes [2]. Thus, elite athletes 
have a higher number of infectious episodes than recreational ath-
letes and the general population [3]. It is worth noting that the 
highest relative incidence of URTI was noted in elite athletes at the 
Winter Olympics, the Summer Olympics and the World Champion-
ships [4-6]. Since URTI is a major problem in athletes, it is impor-
tant to find immune markers which are linked (directly or indirectly) 
to these infections. 
So far it is not known which elements of the immune system 
contribute to the increased incidence of the above-mentioned infec-
tions. One of them could be secretory immunoglobulin A (sIgA). sIgA 
plays a key role in the mucosa-associated lymphoid tissue (MALT), 
which forms the first line of defence against infections of the upper 
respiratory tract [7]. Previous research has shown that exercise 
influences the concentration/secretion rate of sIgA [8, 9], and that 
a low level of sIgA could be associated with increased frequency of 
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upper respiratory tract infections in athletes [10]. The concentration 
of sIgA in saliva depends on the synthesis of this immunoglobulin 
and the efficiency of its transport across the mucosa. 
Local plasma cells produce sIgA at mucosal sites. This process 
is regulated by cytokines [7]. Interleukin-5 (IL-5) is one of the most 
important cytokines responsible for triggering the production of 
sIgA [11, 12]. IL-5 is produced by Th2 cells, mast cells and eo-
sinophils and modulates inflammatory, innate and acquired immune 
responses [12]. It is well known that intense exercise produces 
a rapid, transient increase in cytokine production (for example IL-6, 
IL-10, IL-1ra and IFN-γ) [13, 14]. In contrast, IL-5 production de-
creases after resistance exercise [15]. 
No specific gene or genetic mechanism has yet been suggested 
which could link the metabolic effects of intensive endurance train-
ing with the secretion of sIgA and blood concentration of IL-5. Nev-
ertheless, it seems probable that the activity of some important 
genomic pathways, which maintain the metabolic homeostasis in 
blood lymphocytes, corresponds with the sIgA or IL-5 levels. There-
fore we aimed to assess the whole genome expression in blood of 
athletes in the hope of detecting genes that may be responsible for 
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modulation of sIgA or IL-5 levels. Identifying such genes would 
contribute to the understanding of immunological mechanisms re-
sponsible for decreased immunity in elite athletes and could con-
tribute to optimization of their training schemes to avoid infections 
and episodes of absence during sports championships.
MATERIALS AND METHODS 
Participants. A group of 10 international-class kayakers (six men 
aged 23.3 ± 0.4 and four women aged 26.7 ± 2.6 years) agreed 
to participate in this pilot study. The potential correlation of sIgA and 
IL-5 concentrations and of genome expression in white blood cells 
(in particular of the genes important for the immunologic response 
to viral infections) was analysed in study participants. The protocol 
of the study was approved by the Ethical Research Committee at the 
Institute of Sport in Warsaw. Information about the study was given 
to the participants, who signed an informed consent form.
In order to exclude participants potentially suffering from a chron-
ic infection, physical examination of each athlete was performed with 
additional assessment of CRP concentrations and white blood cell 
counts in blood. 
Blood and saliva collection and analysis
The blood and saliva were collected from healthy, medically examined 
athletes, who had returned from a training camp. Sample collection 
was performed on the same day in the morning, after overnight fast-
ing and in a seated position.
The blood samples were collected from the antecubital vein. White 
blood cell (WBC) counts were measured using the ADVIA 120 hae-
matology analyser (Siemens, Germany). Concentration of C-reactive 
protein (CRP) in serum was determined using the immunoturbidi-
metric method (Pentra, Japan). The concentration of IL-5 in serum 
was measured using a specific ELISA kit (SunRed, Shanghai). All 
serum samples were frozen at -80°C until analysis. All assays were 
performed in duplicate. 
Approximately 5 minutes before saliva collection all athletes were 
required to rinse the mouth with plain water. The unstimulated sa-
liva samples were collected by passive dribble into a sterile collection 
tube. After centrifugation for 15 min at 3000 rpm, saliva samples 
were stored frozen at -20ºC prior to analysis. Salivary sIgA was 
analysed using commercially available ELISA kits (DIAMETRA, Italy) 
according to the manufacturer’s protocol. All assays were performed 
in duplicate.
The study participants were stratified into subgroups with above-
mean and below-mean concentrations of sIgA and IL-5. Subsequent-
ly, the genome expression profiles were compared between athletes 
with above-mean concentrations of sIgA or IL-5 and those in whom 
below-mean concentrations of sIgA or IL-5, respectively, were de-
tected (Table 1). 
A sample of 2.5 ml of blood was obtained from every person in 
order to extract total RNA (the PAXgene system manufactured by 
PreAnalytiX was used). Subsequently, the whole genome expression 
was assessed using SurePrint Human Gene Expression 8x60K v2 
Microarrays (Agilent, USA) according to the manufacturer’s protocol. 
The microarrays were scanned on the Agilent SureScan G2600D 
scanner. 
SurePrint G3 Human Gene Expression Microarrays provide com-
prehensive coverage of the entire human genome (50.599 genes 
and transcripts) with high specificity of target detection and a very 
wide dynamic range allowing for detection of biological features both 
with very high and with very low expression. 
Statistical analysis 
GeneSpring software (www.genespring.com) was used to perform 
data analysis. The single colour expression technology designed for 
Agilent microarrays was applied. A standard statistical procedure 
allowing for analysis of small sample sets was chosen. The moder-
ated t-test with the Westfall-Young permutative correction for mul-
tiple testing was used to detect statistically significant differences 
TABLE 1. Characteristics of study participants and results of genomic analysis.
Gender sIgA concentration [µl·ml-1]
IL-5 concentration 
[pg·ml-1]
Differently expressed transcripts
Comparison of groups with sIgA 
above vs below mean (136.6)
Comparison of groups with IL-5 
above vs below mean (18.25)
1 F 72.07 8.28
Up-regulated: 
LOC101928738, RFX3, lnc-
TMEM132D-2, SLC15A2, 
ACTR3C, HOMER1, TMTC1, 
C7orf61, H6PD
Down-regulated: 
XLOC_l2_002477, 
LOC101927895, ADTRP, DDTL, 
ELOVL6, ZNF606, LINC00476, 
LOC100507250, LCE3C, CELA1
Up-regulated: 
FAM106A, lnc-DHX37-10, 
MIAT, LOC283788, LINC01395, 
PARPBP, TGFBR3L, lnc-PIK3R1-1
Down-regulated: 
lnc-TP53I11-1, FAM208B, 
ZNF606, XLOC_l2_009182, 
SCGB1C1, LOC221946, lnc-
RP11-736N17.6.1-1, RWDD4, 
TRIM23
2 M 91.39 13.05
3 M 92.92 8.83
4 M 100.38 12.78
5 F 136.39 15.83
6 F 154.20 11.93
7 F 156.43 32.81
8 M 162.25 23.97
9 M 186.13 20.42
10 M 214.22 34.61
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between the two subgroups of study participants. The corrected 
value of p<0.05 was considered significant. The transcripts reveal-
ing a fold change value (FC) >2 were further analysed. 
RESULTS 
Table 1 presents the results of the initial blood and saliva tests per-
formed in study participants. Blood leukocyte counts and CRP con-
centrations were within the normal range in all of them. The mean 
concentration of sIgA was 136.6 µl·ml-1 and the mean concentration 
of IL-5 was 18.25 pg/ml. The group of athletes with higher (N=5) 
and with lower (N=5) concentrations of sIgA differed significantly 
with regard to 19 transcripts. None of them seemed to be involved 
in the pathophysiology of upper respiratory tract infections. The ge-
nomic analysis also identified 17 transcripts expressed differently 
between the athletes with higher (N=4) and with lower (N=6) 
concentrations of IL-5. Interestingly, one of these transcripts represents 
a gene involved in development of the common cold – secretoglobin 
1C1 (SCGB1C1, ligand binding protein RYD5). The above transcript 
was down-regulated in athletes with higher IL-5 concentrations (cor-
rected p=0.00065; fold change=3.17).
DISCUSSION 
The prevalence of upper respiratory tract infections is influenced by 
environmental, immunological (adaptive and innate) and genetic 
factors. The heritability of the genetic component for recurrent URTI 
was estimated at approximately 60% based on a twin study [16]. 
However, little is known about the role of specific genes [17]. Recent 
work showed that the IFITM3 and Mx1 genes are important in host 
susceptibility to influenza [18]. Some studies have suggested that 
cytokine gene polymorphisms (for example for IL-10 and IL-6) may 
contribute to the variable risk of development of URTI in highly trained 
athletes [19, 20]. Previous studies have also demonstrated that low 
levels of sIgA or of sIgA fractions may be associated with upper re-
spiratory tract infections in athletes [10], but the role of IL-5 in URTI 
is not clear [19, 21, 22]. 
The main finding of our study is the correlation of high IL-5 
concentration with decreased activity of the secretoglobin 1C1 
gene (SCGB1C1). Secretoglobins are found at high concentrations 
in many secretions, including uterine, prostatic, pulmonary, lacrimal 
and salivary glands. The expression of SCGB1C1 was also found in 
human upper respiratory airway mucosa, where it is regulated by 
different cytokines – down-regulated by IFN-γ and up-regulated by 
IL-4 and IL-13 [23]. The SCGB1C1 protein plays a role in primary 
defence mechanisms by recognizing and removing pathogenic mi-
croorganisms from the mucosa and also by protecting lung epithe-
lial cells [24, 25]. Moreover, the SCGB1C1 protein may be involved 
in development of the common cold [25; Gene Ontology, 
GO:0005576]. On the other hand, it is well known that Th1/Th2 
balance is important in maintaining host immune response. T lym-
phocytes produce interleukins, which play a role in host protection 
against infection. Th1 cells produce predominantly IFN-γ, TNF-α and 
IL-2, whereas Th2 cells are responsible for the production of IL-4, 
IL-5, IL-6 and IL-10 [26]. It was found that strenuous exercise could 
affect expression of genes encoding transcription factors associated 
with cytokine production, which induces a shift in the Th1/Th2 bal-
ance to Th2 predominance [27]. Th1/Th2 imbalance may contribute 
to increased URTI [27]. Gleeson et al. (2012) [21] demonstrated 
that high IL-10 production in response to antigen challenge in illness-
prone athletes may be a risk factor for development of URTI. They 
also support the hypothesis that decreased Th1 responses are re-
sponsible for higher incidence of URTI. It was also demonstrated that 
83% of children with 2009 H1N1 pneumonia had an elevated serum 
level of IL-5 in the first 24 hours after the onset of fever, indepen-
dently of the presence of underlying allergies [28]. Elevation of IL-5 
concentration in the blood was also observed in children with rhino-
virus-induced wheezing [29]. The above-mentioned data may suggest 
that an increased concentration of IL-5 may impair the protective 
role of SCGB1C1 in respiratory airway mucosa, which in turn may 
increase the frequency of developing URTI. Animal studies support 
this hypothesis, as IL-5 may suppress expression of one of the anti 
inflammatory proteins from the secretoglobin family (SCGB3A2) in 
murine lung tissue [30]. Thus, the relationship between IL-5 and 
SCGB1C1 which was observed in our study may reflect an important 
biological phenomenon.
Several limitations of this preliminary study should be taken into 
account. First of all, the whole genome assessment was performed 
only in a few samples, and application of multi-stage statistical meth-
ods with correction for multiple comparisons was necessary in this 
analysis. Gene expression profiling studies are highly complex. The 
large amount of genomic data results in a high probability for errors. 
The search for differentially expressed genes includes data normaliza-
tion and interpretation, before the biological question can be addressed. 
However, the final list of differently expressed genes depends not only 
on the statistical methods, but also on the potential selection bias of 
the sample sets to be tested. The small sample size increases the risk 
of incidental, false-positive results and the risk of selection bias. 
In addition, various inter-individual biological differences and sev-
eral environmental factors which were not addressed in our analysis 
may influence immunity in athletes. Thus, further, prospective stud-
ies and larger sample sets are necessary to confirm the potential role 
of the SCGB1C1 gene expression level as a potential marker of re-
sistance to upper respiratory tract infections.
CONCLUSIONS 
In conclusion, we observed an inverse correlation between blood 
expression of the SCGB1C1 gene (which probably closely reflects 
mucosal concentration of SCGB1C1 protein) and the blood expression 
of the IL-5 gene. This mechanism could provide one explanation of 
the frequently observed sudden episodes of immunological dysfunc-
tion resulting in development of the common cold in high-endurance 
athletes. However, the role of IL-5 and sIgA in the host response to 
URTI needs further clarification [28, 31].
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